Skip to content
10-K

Annual Report

BioCrude Technologies USA, Inc.

0001731122-25-000459

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 15, 2025 50.85M sh
Capex FY 2024 · Dec 31, 2024 $2.55K
Capex FY 2024 · Dec 31, 2023 $2.24K
Shares Diluted FY 2024 · Dec 31, 2023 50.78M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$164.15K
Short Term Debt FY 2024 · Dec 31, 2023 $133.97K
Stockholders Equity FY 2024 · Dec 31, 2023 −$234.08K
Current Liabilities FY 2024 · Dec 31, 2023 $253.99K
Total Liabilities FY 2024 · Dec 31, 2023 $253.99K
Total Assets FY 2024 · Dec 31, 2023 $15.93K
Eps Diluted FY 2024 · Dec 31, 2023 $0.00
Eps Basic FY 2024 · Dec 31, 2023 $0.00
Sga Expense FY 2024 · Dec 31, 2023 $240.44K
Net Income FY 2024 · Dec 31, 2023 −$244.19K
Operating Income FY 2024 · Dec 31, 2023 −$240.44K